<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <title>PromptGenix – Facilities & Environment</title>
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="description" content="PromptGenix facilities and environment supporting Phase I development and validation."/>
  <style>
    *{ box-sizing:border-box; }
    body{
      margin:0;
      font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",sans-serif;
      background:#020617;
      color:#e5e7eb;
      line-height:1.5;
    }
    a{ color:inherit; text-decoration:none; }
    .page{ min-height:100vh; display:flex; flex-direction:column; }

    header{
      position:sticky; top:0; z-index:30;
      backdrop-filter: blur(14px);
      background: rgba(15, 23, 42, 0.92);
      border-bottom: 1px solid rgba(148, 163, 184, 0.3);
    }
    .nav{
      max-width:1120px; margin:0 auto; padding:14px 20px;
      display:flex; align-items:center; justify-content:space-between; gap:18px;
    }
    .nav-left{ display:flex; align-items:center; gap:12px; }
    .logo-dot{
      width:28px; height:28px; border-radius:999px;
      background: radial-gradient(circle at 0 0,#38bdf8,#8b5cf6);
      box-shadow:0 0 18px rgba(56,189,248,.7);
    }
    .brand{ font-size:1.1rem; font-weight:650; letter-spacing:.04em; }
    .subbrand{ font-size:.72rem; color:#9ca3af; margin-top:2px; }

    .nav-links{ display:flex; gap:10px; flex-wrap:wrap; justify-content:flex-end; }
    .nav-links a{
      font-size:.88rem; color:#9ca3af;
      padding:6px 10px; border-radius:999px;
      border:1px solid rgba(148,163,184,0.18);
      background: rgba(2,6,23,0.25);
    }
    .nav-links a:hover{
      color:#e5e7eb;
      background: rgba(148,163,184,0.18);
      border-color: rgba(148,163,184,0.35);
    }
    .nav-links a.active{
      color:#e5e7eb;
      background: rgba(148,163,184,0.18);
      border-color: rgba(148,163,184,0.55);
    }

    main{ flex:1; }
    .section{
      max-width:1120px;
      margin:0 auto;
      padding:28px 20px;
    }

    .topline{
      display:flex; flex-wrap:wrap; gap:10px;
      align-items:flex-end; justify-content:space-between;
      padding-top: 16px;
      margin-bottom: 14px;
    }
    .doc-title{
      font-size: 1.35rem;
      font-weight: 820;
      color:#f9fafb;
      margin: 0;
    }
    .meta{
      font-size:.78rem;
      color:#9ca3af;
    }

    .kicker{
      font-size:.78rem;
      text-transform:uppercase;
      letter-spacing:.18em;
      color:#a5b4fc;
      margin-bottom:6px;
    }
    h2{
      font-size:1.12rem;
      font-weight:760;
      color:#f9fafb;
      margin:14px 0 8px;
    }
    p{
      margin:0 0 10px;
      font-size:.93rem;
      color:#d1d5db;
    }

    .grid-2{
      display:grid;
      grid-template-columns: minmax(0,1.05fr) minmax(0,1fr);
      gap:18px;
      align-items:start;
      margin-top:10px;
    }
    .grid-3{
      display:grid;
      grid-template-columns: repeat(3, minmax(0,1fr));
      gap:14px;
      margin-top:10px;
    }

    .card{
      border-radius:16px;
      padding:14px 16px;
      background: rgba(15,23,42,0.84);
      border: 1px solid rgba(148,163,184,0.28);
      box-shadow: 0 18px 45px rgba(15,23,42,0.55);
    }
    .card h3{
      margin:0 0 8px;
      font-size:.95rem;
      letter-spacing:.14em;
      text-transform:uppercase;
      color:#a5b4fc;
    }

    ul{
      margin:6px 0 0;
      padding-left:1.1rem;
      color:#d1d5db;
      font-size:.92rem;
    }
    li{ margin-bottom:6px; }
    li strong{ color:#e5e7eb; }

    .pill-row{ display:flex; flex-wrap:wrap; gap:8px; margin-top:10px; }
    .pill{
      font-size:.72rem;
      padding:5px 9px;
      border-radius:999px;
      border:1px solid rgba(129,140,248,0.45);
      background: rgba(2,6,23,0.25);
      color:#c7d2fe;
    }

    .callout{
      border-radius:14px;
      padding:12px 14px;
      border:1px dashed rgba(148,163,184,0.5);
      background: rgba(15,23,42,0.75);
      font-size:.88rem;
      color:#e5e7eb;
      margin-top:12px;
    }
    .callout strong{ color:#22c55e; }

    .table{
      width:100%;
      border-collapse: collapse;
      margin-top:10px;
      border-radius:14px;
      overflow:hidden;
      border:1px solid rgba(148,163,184,0.28);
      background: rgba(15,23,42,0.6);
    }
    .table th, .table td{
      padding:10px 10px;
      border-bottom:1px solid rgba(148,163,184,0.18);
      vertical-align:top;
      font-size:.88rem;
      color:#d1d5db;
    }
    .table th{
      font-size:.78rem;
      text-transform:uppercase;
      letter-spacing:.14em;
      color:#a5b4fc;
      background: rgba(2,6,23,0.35);
    }

    footer{
      border-top:1px solid rgba(31,41,55,0.9);
      padding:16px;
      font-size:.78rem;
      color:#6b7280;
      text-align:center;
    }

    @media (max-width: 980px){
      .grid-3{ grid-template-columns: minmax(0,1fr); }
    }
    @media (max-width: 920px){
      .grid-2{ grid-template-columns: minmax(0,1fr); }
    }

    /* Print friendliness */
    @media print {
      header, footer { display: none !important; }
      .page, main, body { min-height: auto !important; height: auto !important; }
      main { flex: none !important; }

      body { background:#fff !important; color:#111 !important; }
      p, li { color:#111 !important; }
      h1, h2, h3 { color:#111 !important; }
      a { color:#111 !important; text-decoration: none !important; }
      * { box-shadow: none !important; }

      @page { size: Letter; margin: 0.5in; }
      body { font-size: 95%; line-height: 1.32; }

      table, thead, tbody, tr, td, th,
      .grid-2, .card, .callout {
        break-inside: auto !important;
        page-break-inside: auto !important;
      }
      h2, h3 { break-after: avoid-page; page-break-after: avoid; }
      p, li { orphans: 2; widows: 2; }

      .section { max-width: 100% !important; padding: 0 !important; margin: 0 0 0.18in 0 !important; }
      .topline { padding-top: 0 !important; margin-bottom: 0.12in !important; }
      .card { padding: 10px 12px !important; }
      .table th, .table td { padding: 7px 8px !important; }
    }
  </style>
</head>

<body>
<div class="page">
  <header>
    <div class="nav">
      <div class="nav-left">
        <div class="logo-dot"></div>
        <div>
          <div class="brand">PromptGenix</div>
          <div class="subbrand">SBIR Portal</div>
        </div>
      </div>

      <nav class="nav-links">
        <a href="index.html">Portal</a>
        <a href="sbir.html">SBIR</a>
        <a href="aims.html">Aims</a>
        <a href="approach.html">Approach</a>
        <a href="commercialization.html">Commercialization</a>
        <a href="facilities.html" class="active">Facilities</a>
        <a href="team.html">Team</a>
        <a href="use-cases.html">Use Cases</a>
      </nav>
    </div>
  </header>

  <main>
    <section class="section">
      <div class="topline">
        <h1 class="doc-title">Facilities & Environment</h1>
        <div class="meta">
          PromptGenix LLC &middot; Contact: dohoon.kim1@icloud.com &middot; promptgenix.org
        </div>
      </div>

      <div class="kicker">Overview</div>
      <h2>Phase I execution is supported by a modern local compute environment and secure, cloud-ready workflows.</h2>
      <p>
        PromptGenix Phase I focuses on an <strong>evidence-weighted hypothesis intelligence engine</strong> that integrates public biomedical datasets
        and literature. Development is supported by a dedicated local workstation for rapid iteration and deterministic reruns, with an optional
        secure cloud path (e.g., AWS VPC) for scalability and collaboration testing as needed.
      </p>
      <p>
        Phase I validation will use <strong>public datasets only</strong> to avoid IP and data-use constraints, while demonstrating feasibility,
        reproducibility, and transparent evidence linking suitable for SBIR review.
      </p>

      <div class="grid-2">
        <div class="card">
          <h3>Local development environment</h3>
          <ul>
            <li><strong>Dedicated workstation:</strong> high-memory Mac Studio-class system for rapid prototyping and iterative development</li>
            <li><strong>Core toolchain:</strong> Python/R for evidence feature extraction, inference, and report generation</li>
            <li><strong>Reproducibility:</strong> versioned environments, pinned dependencies, config snapshots, and checksums</li>
            <li><strong>Artifacts:</strong> exportable HTML/PDF reports, evidence objects, and audit-friendly logs</li>
          </ul>
          <div class="pill-row">
            <span class="pill">Local-first</span>
            <span class="pill">Deterministic reruns</span>
            <span class="pill">Evidence objects</span>
            <span class="pill">HTML/PDF outputs</span>
          </div>
        </div>

        <div class="card">
          <h3>Secure & scalable deployment option</h3>
          <ul>
            <li><strong>AWS-ready architecture:</strong> supports deployment in a secure VPC for scale testing and controlled collaboration</li>
            <li><strong>Data separation:</strong> Phase I uses public data; sensitive datasets remain external to PromptGenix environments</li>
            <li><strong>Controlled access:</strong> role-based access patterns and audit-friendly storage options (as applicable)</li>
            <li><strong>Portability:</strong> reproducible configs enable consistent execution across local and cloud contexts</li>
          </ul>
          <div class="callout">
            <strong>Phase I policy alignment:</strong> evaluation uses GEO/SRA/FlowRepository and public literature sources to ensure clean SBIR review.
          </div>
        </div>
      </div>

      <div class="kicker" style="margin-top:18px;">Resources supporting Phase I</div>
      <h2>Software, public datasets, and operational supports aligned to SBIR deliverables.</h2>

      <div class="grid-3">
        <div class="card">
          <h3>Software stack</h3>
          <ul>
            <li><strong>Evidence layer:</strong> standardized extraction of effect sizes, uncertainty, reproducibility, and context descriptors</li>
            <li><strong>Inference:</strong> statistical scoring + Bayesian updating for posterior confidence estimates</li>
            <li><strong>Interpretability:</strong> LLM used only for explanation constrained by evidence links (“no evidence → no claim”)</li>
          </ul>
        </div>

        <div class="card">
          <h3>Validation sources</h3>
          <ul>
            <li><strong>Public datasets:</strong> GEO/SRA (omics) and FlowRepository (immune profiling)</li>
            <li><strong>Public literature:</strong> PubMed/PMC for priors and traceable citations</li>
            <li><strong>Evaluation focus:</strong> traceability, reproducibility, calibrated uncertainty, and utility</li>
          </ul>
        </div>

        <div class="card">
          <h3>Operational supports</h3>
          <ul>
            <li><strong>Documentation:</strong> SBIR portal pages + reviewer-ready evidence-linked reports</li>
            <li><strong>Pilot readiness:</strong> structured onboarding and feedback templates for partner labs</li>
            <li><strong>Collaboration:</strong> mechanisms to support letters of support and Phase II pilot expansion</li>
          </ul>
        </div>
      </div>

      <div class="kicker" style="margin-top:18px;">Facilities fit to the work</div>
      <h2>Environment supports rapid prototyping, reproducible validation, and SBIR-compliant evaluation.</h2>

      <table class="table" aria-label="Facilities fit table">
        <thead>
          <tr>
            <th style="width:34%;">Need</th>
            <th style="width:33%;">Environment support</th>
            <th style="width:33%;">Phase I output</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td><strong>Fast iteration</strong></td>
            <td>Local compute enables rapid evidence-layer development, inference tuning, and report refinement</td>
            <td>Stable end-to-end hypothesis ranking on multiple public datasets with deterministic reruns</td>
          </tr>
          <tr>
            <td><strong>Reproducibility</strong></td>
            <td>Pinned versions, config snapshots, and checksums; exportable evidence objects and logs</td>
            <td>Rerun-consistent outputs; reviewer-ready artifacts with traceability and uncertainty labeling</td>
          </tr>
          <tr>
            <td><strong>Scalability testing</strong></td>
            <td>Cloud-ready execution path (optional) for heavier workloads and multi-user patterns</td>
            <td>Feasibility evidence for Phase II secure deployments and multi-site pilots</td>
          </tr>
        </tbody>
      </table>

      <div class="callout">
        <strong>Bottom line:</strong> The current facilities and environment are sufficient to deliver Phase I milestones
        (evidence ingest, hypothesis prioritization, traceable reporting, and measurable validation on public data),
        while maintaining a clean path to secure scale-out in Phase II.
      </div>
    </section>
  </main>

  <footer>
    PromptGenix &middot; SBIR Portal &middot;
    <a href="mailto:dohoon.kim1@icloud.com">dohoon.kim1@icloud.com</a>
  </footer>
</div>
</body>
</html>
